Standardising definitions for the pre-eclampsia core outcome set: A consensus development study.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 18 04 2020
revised: 06 06 2020
accepted: 14 06 2020
pubmed: 17 7 2020
medline: 28 5 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

To develop consensus definitions for the core outcome set for pre-eclampsia. Potential definitions for individual core outcomes were identified across four formal definition development initiatives, nine national and international guidelines, 12 Cochrane systematic reviews, and 79 randomised trials. Eighty-six definitions were entered into the consensus development meeting. Ten healthcare professionals and three researchers, including six participants who had experience of conducting research in low- and middle-income countries, participated in the consensus development process. The final core outcome set was approved by an international steering group. Consensus definitions were developed for all core outcomes. When considering stroke, pulmonary oedema, acute kidney injury, raised liver enzymes, low platelets, birth weight, and neonatal seizures, consensus definitions were developed specifically for low- and middle-income countries because of the limited availability of diagnostic interventions including computerised tomography, chest x-ray, laboratory tests, equipment, and electroencephalogram monitoring. Consensus on measurements for the pre-eclampsia core outcome set will help to ensure consistency across future randomised trials and systematic reviews. Such standardization should make research evidence more accessible and facilitate the translation of research into clinical practice. Video abstract can be available at: www.dropbox.com/s/ftrgvrfu0u9glqd/6.%20Standardising%20definitions%20in%20teh%20pre-eclampsia%20core%20outcome%20set%3A%20a%20consensus%20development%20study.mp4?dl=0.

Identifiants

pubmed: 32674052
pii: S2210-7789(20)30086-6
doi: 10.1016/j.preghy.2020.06.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-217

Subventions

Organisme : Department of Health
ID : NIHR-RP-02-12-015
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0614-20005
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/15/32/31604
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N008405/1
Pays : United Kingdom
Organisme : Department of Health
ID : DRF-2014-07-051
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2014-05-019
Pays : United Kingdom

Informations de copyright

Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Auteurs

James M N Duffy (JMN)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; Institute for Women's Health, University College London, London, United Kingdom. Electronic address: james.duffy3@nhs.net.

Alexandra E Cairns (AE)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

Laura A Magee (LA)

Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom.

Peter von Dadelszen (P)

Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom.

Janneke van 't Hooft (J)

Department of Obstetrics and Gynecology, Amsterdam UMC, Academic Medical Center, Amsterdam, Netherlands.

Chris Gale (C)

Academic Neonatal Medicine, Imperial College London, London, United Kingdom.

Mark Brown (M)

Department of Renal Medicine, St George Hospital and University of New South Wales, Kogarah, Australia.

Lucy C Chappell (LC)

Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom.

William A Grobman (WA)

Department of Obstetrics and Gynaecology, Feinberg School of Medicine, Northwestern University, Chicago, United States.

Ray Fitzpatrick (R)

Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

S Ananth Karumanchi (SA)

Cedars-Sinai Medical Center, Los Angeles, CA, United States.

D Nuala Lucas (DN)

London North West University Healthcare NHS Trust, Harrow, United Kingdom.

Ben Mol (B)

Women's Health Care Research Group, Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.

Michael Stark (M)

Department of Obstetrics and Gynaecology, University of Adelaide, Adelaide, Australia.

Shakila Thangaratinam (S)

Women's Health Research Unit, Barts and The London School of Medicine and Dentistry, London, United Kingdom.

Mathew J Wilson (MJ)

School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom.

Paula R Williamson (PR)

MRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.

Sue Ziebland (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

Richard J McManus (RJ)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH